Yoav Artzi clashes over AI drug discovery: 'understanding' maps to FDA approval

tallinzen · x · 2026-10-12

Yoav Artzi weighs in on an AI-in-pharma debate centered on what "understand" means. He argues that in this domain, understanding maps to the drug testing and approval process (the FDA in the US) — ignoring that mapping is curmudgeonly at best, self-serving at worst, even for stage 4 patients on experimental treatments.

Original post →

More from Fun

Fun channel →